Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
44.26
-0.45 (-1.01%)
At close: Dec 5, 2025, 4:00 PM EST
44.28
+0.02 (0.05%)
After-hours: Dec 5, 2025, 5:59 PM EST
Dianthus Therapeutics Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Dianthus Therapeutics stock ranges from a low of $46 to a high of $100. The average analyst price target of $68 forecasts a 53.64% increase in the stock price over the next year.
Price Target: $68.00 (+53.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Dianthus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 5 | 6 | 6 | 6 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 10 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $47 | Strong Buy | Maintains | $40 → $47 | +6.19% | Nov 10, 2025 |
| Wedbush | Wedbush | Buy Maintains $44 → $46 | Buy | Maintains | $44 → $46 | +3.93% | Nov 6, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $56 | Strong Buy | Initiates | $56 | +26.53% | Oct 14, 2025 |
| Clear Street | Clear Street | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +125.94% | Sep 17, 2025 |
| Stifel | Stifel | Strong Buy Maintains $52 → $65 | Strong Buy | Maintains | $52 → $65 | +46.86% | Sep 12, 2025 |
Financial Forecast
Revenue This Year
2.18M
from 6.24M
Decreased by -65.12%
Revenue Next Year
1.48M
from 2.18M
Decreased by -31.95%
EPS This Year
-3.72
from -2.55
EPS Next Year
-3.69
from -3.72
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.3M | 4.2M | ||||
| Avg | 2.2M | 1.5M | ||||
| Low | 1.7M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -47.1% | 93.1% | ||||
| Avg | -65.1% | -32.0% | ||||
| Low | -72.8% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.34 | -3.16 | ||||
| Avg | -3.72 | -3.69 | ||||
| Low | -4.39 | -4.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.